Table 2.

Engraftment of Congenic Marrow in Mice After131I-Anti-CD45 Antibody

Administered 131I Activity% Donor Granulocytes (mean ± SD)% Donor T Cells (mean ± SD)
28 d After BMT 113 d After BMT 28 d After BMT 113 d After BMT
0 (Ab only)  4.9 ± 5.6  1.6 ± 0.9 0 ± 0  0.1 ± .2  
0.5 mCi  81.3 ± 7.5 86.6 ± 7.0  34.7 ± 8.1  80.4 ± 7.6  
1.0 mCi 92.7 ± 3.5  91.5 ± 3.7  38.5 ± 9.4 87.6 ± 3.5  
1.25 mCi  96.0 ± 2.9  95.8 ± 3.2 44.9 ± 9.8  89.1 ± 4.9  
1.5 mCi  98.3 ± 1.4 94.9 ± 7.7  38.1 ± 14.8  89.8 ± 4.3 
Administered 131I Activity% Donor Granulocytes (mean ± SD)% Donor T Cells (mean ± SD)
28 d After BMT 113 d After BMT 28 d After BMT 113 d After BMT
0 (Ab only)  4.9 ± 5.6  1.6 ± 0.9 0 ± 0  0.1 ± .2  
0.5 mCi  81.3 ± 7.5 86.6 ± 7.0  34.7 ± 8.1  80.4 ± 7.6  
1.0 mCi 92.7 ± 3.5  91.5 ± 3.7  38.5 ± 9.4 87.6 ± 3.5  
1.25 mCi  96.0 ± 2.9  95.8 ± 3.2 44.9 ± 9.8  89.1 ± 4.9  
1.5 mCi  98.3 ± 1.4 94.9 ± 7.7  38.1 ± 14.8  89.8 ± 4.3 

Engraftment of T-cell–depleted C57BL/6 marrow in B6-Ly5a recipients. Values are the mean for 3 (antibody only) to 5 or 6 mice per group.

Close Modal

or Create an Account

Close Modal
Close Modal